Pfizer
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pfizer and other ETFs, options, and stocks.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.
PFE Key Statistics
PFE News
In the latest trading session, Pfizer (PFE) closed at $40.81, marking a +1.77% move from the previous day. This change outpaced the S&P 500's 0.89% gain on the...
The Nasdaq Composite traded slightly higher on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates th...
Over the past year, many Pfizer Inc. ( ) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insider tra...
Analyst ratings
59%
of 22 ratingsPFE Earnings
More PFE News
Pfizer, Inc. PFE announced that the FDA’s Antimicrobial Drugs Advisory Committee (AMDAC) voted 16 to 1 in favor of Paxlovid for the treatment of mild-to-moderat...
https://cdn.benzinga.com/files/images/story/2023/03/17/pfe.png?optimize=medium&dpr=2&auto=webp&crop=1200%2C800 Pfizer Inc (NYSE: PFE) and Astellas Pharma Inc (...
https://cdn.benzinga.com/files/images/story/2023/03/17/paxlovid.png?optimize=medium&dpr=2&auto=webp&crop=1200%2C800 The FDA's Antimicrobial Drugs Advisory Comm...
https://cdn.benzinga.com/files/images/story/2023/03/17/pfizer_finland_hq_february_13_2009.jpg?optimize=medium&dpr=2&auto=webp&crop=1200%2C800 Pfizer Inc (NYSE:...
This week, M&A activity picked up momentum in the drug and biotech sector, with Pfizer PFE announcing a huge $43 billion offer for another cancer drugmaker, Sea...
The target Prescription Drug User Fee Act (PDUFA) action date for a decision by the FDA is May 2023 NEW YORK, March 16, 2023--(BUSINESS WIRE)--Pfizer Inc. (NYS...
A Food and Drug Administration advisory committee voted 16-1 that the benefits of Pfizer’s PFE COVID antiviral Paxlovid outweigh the risks in adults who are at...
